ORS 689.813 Exemption from drug labeling requirements

A requirement that a health care provider who is authorized to prescribe drugs in this state label a drug dispensed by the health care provider with the information described in subsection (2) of this section does not apply to a drug approved by the United States Food and Drug Administration for the reversal of an opioid overdose if the drug is:

In the form of a nasal spray; and

Personally dispensed by a health care provider described in this subsection at the location of practice of the health care provider.

The information described in subsection (1) of this section includes:

The name of the patient;

The name and address of the dispensing health care provider;

The date of dispensing;

The name of the drug or, if the dispensed drug does not have a brand name, the generic name of the drug along with the name of the drug distributor or manufacturer;

The drug’s quantity per unit, unless the drug is a compound; and

The directions for the drug’s use stated in the prescription;

Cautionary statements, if any, as required by law; and

When applicable and as determined by the State Board of Pharmacy, an expiration date after which the patient should not use the drug.